These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 7882277)
1. Tissue-type plasminogen activator predicts endocrine responsiveness of human pancreatic carcinoma cells. Kuramoto M; Yamashita J; Ogawa M Cancer; 1995 Mar; 75(6):1263-72. PubMed ID: 7882277 [TBL] [Abstract][Full Text] [Related]
2. Medroxyprogesterone acetate inhibits human pancreatic carcinoma cell growth by inducing apoptosis in association with Bcl-2 phosphorylation. Abe M; Yamashita J; Ogawa M Cancer; 2000 May; 88(9):2000-9. PubMed ID: 10813710 [TBL] [Abstract][Full Text] [Related]
3. Five novel hormone-responsive cell lines derived from murine mammary ductal carcinomas: in vivo and in vitro effects of estrogens and progestins. Lanari C; Lüthy I; Lamb CA; Fabris V; Pagano E; Helguero LA; Sanjuan N; Merani S; Molinolo AA Cancer Res; 2001 Jan; 61(1):293-302. PubMed ID: 11196177 [TBL] [Abstract][Full Text] [Related]
4. Endocrine therapy in pancreatic carcinoma. Yamashita J; Abe M; Ogawa M Oncology; 1998 Dec; 55 Suppl 1():17-22. PubMed ID: 9852398 [TBL] [Abstract][Full Text] [Related]
5. The effect of second-line antiestrogen therapy on breast tumor growth after first-line treatment with the aromatase inhibitor letrozole: long-term studies using the intratumoral aromatase postmenopausal breast cancer model. Long BJ; Jelovac D; Thiantanawat A; Brodie AM Clin Cancer Res; 2002 Jul; 8(7):2378-88. PubMed ID: 12114443 [TBL] [Abstract][Full Text] [Related]
6. Endocrine-responsive pancreatic carcinoma: steroid binding and cytotoxicity studies in human tumor cell lines. Benz C; Hollander C; Miller B Cancer Res; 1986 May; 46(5):2276-81. PubMed ID: 3697973 [TBL] [Abstract][Full Text] [Related]
7. Tissue plasminogen activator is required for the growth, invasion, and angiogenesis of pancreatic tumor cells. Díaz VM; Planaguma J; Thomson TM; Reventós J; Paciucci R Gastroenterology; 2002 Mar; 122(3):806-19. PubMed ID: 11875015 [TBL] [Abstract][Full Text] [Related]
8. Effect of toremifene on the growth, hormone receptors and insulin-like growth factor-1 of hormone-dependent MCF-7 tumors in athymic mice. Iino Y; Takai Y; Ando T; Sugamata N; Maemura M; Takeo T; Ohwada S; Morishita Y Cancer Chemother Pharmacol; 1993; 32(5):353-8. PubMed ID: 8339385 [TBL] [Abstract][Full Text] [Related]
9. Important roles of estrogen receptor alpha in tumor progression and anti-estrogen therapy of pancreatic ductal adenocarcinoma. Xue J; Yao Y; Yao Q; Tian X; Feng Y; Su H; Kong D; Cui C; Yan L; Hao C; Zhou T Life Sci; 2020 Nov; 260():118302. PubMed ID: 32827543 [TBL] [Abstract][Full Text] [Related]
10. Leukotriene B4 receptor antagonist LY293111 inhibits proliferation and induces apoptosis in human pancreatic cancer cells. Tong WG; Ding XZ; Hennig R; Witt RC; Standop J; Pour PM; Adrian TE Clin Cancer Res; 2002 Oct; 8(10):3232-42. PubMed ID: 12374694 [TBL] [Abstract][Full Text] [Related]
11. Novel antitumor effect of estradiol in athymic mice injected with a T47D breast cancer cell line overexpressing protein kinase Calpha. Chisamore MJ; Ahmed Y; Bentrem DJ; Jordan VC; Tonetti DA Clin Cancer Res; 2001 Oct; 7(10):3156-65. PubMed ID: 11595710 [TBL] [Abstract][Full Text] [Related]
12. Antitumor action of physiological estradiol on tamoxifen-stimulated breast tumors grown in athymic mice. Yao K; Lee ES; Bentrem DJ; England G; Schafer JI; O'Regan RM; Jordan VC Clin Cancer Res; 2000 May; 6(5):2028-36. PubMed ID: 10815929 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-127 is aberrantly downregulated and acted as a functional tumor suppressor in human pancreatic cancer. Yu Y; Liu L; Ma R; Gong H; Xu P; Wang C Tumour Biol; 2016 Oct; 37(10):14249-14257. PubMed ID: 27571739 [TBL] [Abstract][Full Text] [Related]
14. Combined effects of estradiol, leuprorelin, tamoxifen and medroxyprogesterone acetate on cell growth and steroid hormone receptors in breast cancer cells. Sica G; Iacopino F; Robustelli della Cuna G; Marchetti P; Marini L J Cancer Res Clin Oncol; 1994; 120(10):605-9. PubMed ID: 7929532 [TBL] [Abstract][Full Text] [Related]
15. Specific interaction of tissue-type plasminogen activator (t-PA) with annexin II on the membrane of pancreatic cancer cells activates plasminogen and promotes invasion in vitro. Díaz VM; Hurtado M; Thomson TM; Reventós J; Paciucci R Gut; 2004 Jul; 53(7):993-1000. PubMed ID: 15194650 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of Efficacy of Radioimmunotherapy with 90Y-Labeled Fully Human Anti-Transferrin Receptor Monoclonal Antibody in Pancreatic Cancer Mouse Models. Sugyo A; Tsuji AB; Sudo H; Okada M; Koizumi M; Satoh H; Kurosawa G; Kurosawa Y; Saga T PLoS One; 2015; 10(4):e0123761. PubMed ID: 25893775 [TBL] [Abstract][Full Text] [Related]
17. [Expression of angiogenic factors in pancreatic carcinoma cell and their significance]. Yan CQ; Zhao YP Zhonghua Wai Ke Za Zhi; 2009 May; 47(10):787-90. PubMed ID: 19615219 [TBL] [Abstract][Full Text] [Related]
18. Estradiol agonists inhibit human LoVo colorectal-cancer cell proliferation and migration through p53. Hsu HH; Kuo WW; Ju DT; Yeh YL; Tu CC; Tsai YL; Shen CY; Chang SH; Chung LC; Huang CY World J Gastroenterol; 2014 Nov; 20(44):16665-73. PubMed ID: 25469035 [TBL] [Abstract][Full Text] [Related]
19. [Inhibitory effect of FOY-305 on liver metastasis of the pancreatic cancer]. Ohta T; Futagami F; Arakawa H; Tsukioka Y; Kitagawa H; Kayahara M; Nagakawa T; Miyazaki I Gan To Kagaku Ryoho; 1996 Oct; 23(12):1669-72. PubMed ID: 8886041 [TBL] [Abstract][Full Text] [Related]
20. The role of STAT-3 in the induction of apoptosis in pancreatic cancer cells by benzyl isothiocyanate. Sahu RP; Srivastava SK J Natl Cancer Inst; 2009 Feb; 101(3):176-93. PubMed ID: 19176463 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]